JPRN-UMIN000032030已完成未知
Prospective randomized study of safety outcomes treated with edoxaban in patients with stable coronary artery disease and atrial fibrillation - PRAEDO AF study
ihon university school of medicine0 个研究点目标入组 200 人开始时间: 2018年3月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who are contraindicated for edoxaban 2)Patients who are contraindicated for clopidogrel 3)Patients who are going to undergo revascularization 4)Those who are going to undergo invasive surgery (excluding digestive endoscopy and biopsy) 5)Patients who have active tumors 6)Patients who have poorly-controlled hypertension (systolic blood pressure at hospital admission: 160 mmHg or more) 7)Patients judged as inappropriate for this study by investigators
研究者
相似试验
进行中（未招募）
1 期
A prospective, randomised study to access safety, changes in platelet reactivity, plasma cardiac biomarkers and metabolic parameters over 48 weeks in HIV-1 infected subjects undergoing a switch in antiretroviral therapy. - The St. Marys and The Mater Switch Study (SMASH)HIVEUCTR2009-011538-93-IEImperial College London40
招募中
1 期
Polylaminin for Acute Spinal Cord Injurynspecified injury at unspecified level of cervical spinal cordUnspecified injury at unspecified level of thoracic spinal cordG00-G99RBR-9dfvgpmniversidade Federal do Rio de Janeiro
进行中（未招募）
1 期
A prospective, randomised study to assess safety, changes in platelet reactivity, plasma cardiac biomarkers and metabolic parameters over 48 weeks in HIV-1 infected subjects undergoing a switch in antiretroviral therapy. - The St. Marys and The Mater Switch Study (SMASH)HIVEUCTR2009-011538-93-GBImperial College London18
尚未招募
不适用
A comparative study of safety and efficacy of bilastine updosing (40mg) vs combination of bilastine 20mg with levocetrizine 5mg in the treatment of chronic spontaneous urticariaCTRI/2022/10/046449SRM Medical college hospital
进行中（未招募）
1 期
A prospective randomized pilot trial on safety and feasibility of Argatroban as blood thinner in patients with heart-lung machinepatients requiring treatment with extracorporeal membrane oxygenationEUCTR2021-001456-34-ATMedical University of Vienna40